BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12715309)

  • 1. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe.
    Campbell TB; Borok M; White IE; Gudza I; Ndemera B; Taziwa A; Weinberg A; Gwanzura L
    Clin Infect Dis; 2003 May; 36(9):1144-51. PubMed ID: 12715309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women.
    Lampinen TM; Kulasingam S; Min J; Borok M; Gwanzura L; Lamb J; Mahomed K; Woelk GB; Strand KB; Bosch ML; Edelman DC; Constantine NT; Katzenstein D; Williams MA
    J Infect Dis; 2000 May; 181(5):1785-90. PubMed ID: 10823785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of Kaposi's sarcoma-associated herpesvirus viremia during hematopoietic stem cell mobilization with filgrastim.
    Neid JM; Schooley RT; Campbell TB
    Am J Hematol; 2004 Dec; 77(4):410-2. PubMed ID: 15551282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma.
    Pellet C; Chevret S; Francès C; Euvrard S; Hurault M; Legendre C; Dalac S; Farge D; Antoine C; Hiesse C; Peraldi MN; Lang P; Samuel D; Calmus Y; Agbalika F; Morel P; Calvo F; Lebbé C
    J Infect Dis; 2002 Jul; 186(1):110-3. PubMed ID: 12089670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
    Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N
    J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
    Min J; Katzenstein DA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and sequence diversity of Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) DNA.
    Murakami M; Sugita Y; Ishii N; Nagatani T; Ichiyama S; Tamura N; Mohri S; Nakajima H
    Eur J Dermatol; 1999; 9(1):13-6. PubMed ID: 9920979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 strains from Russian patients with classic, posttransplant, and AIDS-associated Kaposi's sarcoma.
    Kadyrova E; Lacoste V; Duprez R; Pozharissky K; Molochkov V; Huerre M; Gurtsevitch V; Gessain A
    J Med Virol; 2003 Dec; 71(4):548-56. PubMed ID: 14556268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
    Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
    J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection.
    Parisi SG; Boldrin C; Andreis S; Ferretto R; Fuser R; Malena M; Manfrin V; Panese S; Scaggiante R; Dori L; Sarmati L; Biasolo MA; Nicastri E; Andreoni M; Cruciani M; Palù G
    J Med Virol; 2011 Mar; 83(3):384-90. PubMed ID: 21264857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.
    Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS
    J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus type 8 genotypes in iatrogenic, classic and AIDS-associated Kaposi's sarcoma from Greece.
    Gazouli M; Papaconstantinou I; Zavos G; Metaxa-Mariatou V; Nasioulas G; Boletis J; Arapadoni-Dadioti P; Giaslakiotis K; Zografidis A; Kostakis A
    Anticancer Res; 2004; 24(3a):1597-602. PubMed ID: 15274328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions.
    Ramos da Silva S; Bacchi MM; Bacchi CE; Elgui de Oliveira D
    Am J Clin Pathol; 2007 Nov; 128(5):794-802. PubMed ID: 17951202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases.
    Campbell TB; Staskus KA; Folkvord J; White IE; Neid J; Zhang XQ; Connick E
    J Infect Dis; 2005 Feb; 191(3):367-71. PubMed ID: 15633095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage.
    Campbell TB; Borok M; Gwanzura L; MaWhinney S; White IE; Ndemera B; Gudza I; Fitzpatrick L; Schooley RT
    AIDS; 2000 Sep; 14(14):2109-16. PubMed ID: 11061651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.